A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in uveal melanoma…

Overview of attention for article published in Frontiers in immunology, October 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)
Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

twitter: 3 X users

Readers on

mendeley: 12 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 2,313 followers.

RT @iCCaRE4BlackMen: #ICCaRE on melanoma by #MPI Dr. Roxana S. Dronca of Mayo Clinic Florida, Jacksonville, FL, United States. A phase I o…

08 Mar 2024

Reply Repost Favourite

RT @iCCaRE4BlackMen: #ICCaRE on melanoma by #MPI Dr. Roxana S. Dronca of Mayo Clinic Florida, Jacksonville, FL, United States. A phase I o…

08 Mar 2024

Reply Repost Favourite

#ICCaRE on melanoma by #MPI Dr. Roxana S. Dronca of Mayo Clinic Florida, Jacksonville, FL, United States. A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase... https://t.co/5mqa2Onazz

07 Mar 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.